US Broker Ratings

IDEXX Laboratories, Inc. (IDXX) Growth Potential: A Deep Dive into its 8.78% Upside and Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the Healthcare sector under the Diagnostics & Research industry, has captured investor attention with its significant market cap of $56.34 billion...

Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 21.3% Upside Potential in Diagnostics & Research

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, stands out with a market capitalization of $39.6 billion and a promising upside potential of 21.3%. The company,..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Growth in Healthcare with a 33.62% ROE

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to capture investor attention with its substantial market cap of $509.76 billion and its robust presence across the..

ResMed Inc. (RMD) Stock Analysis: A 16.59% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a formidable player in the healthcare sector, stands out with a market capitalization of $36.82 billion. Specializing in medical instruments and supplies, ResMed is at the..

DexCom, Inc. (DXCM) Stock Analysis: 26.71% Potential Upside Sparks Investor Interest

DexCom, Inc. (NASDAQ: DXCM) continues to capture the attention of investors with its promising growth trajectory and robust product offerings in the medical device sector, specifically in continuous glucose monitoring..

Boston Scientific Corporation (BSX): Investor Outlook with a 36.62% Upside Potential

Boston Scientific Corporation (NYSE: BSX), a titan in the medical devices industry, is catching the eye of investors with its substantial market capitalization of $137.24 billion and an attractive potential..

GSK plc (GSK) Stock Analysis: A Healthcare Giant with Stable Growth and Dividend Appeal

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as one of the prominent players in the drug manufacturing industry. With a market capitalization of $98.49 billion, this..

AstraZeneca PLC (AZN) Stock Analysis: Discover the 10.16% Upside Potential and Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a global leader in the healthcare sector, has caught the attention of investors with its robust market presence and promising future outlook. With a market capitalization..

Thermo Fisher Scientific (TMO): Robust Analyst Consensus and Solid Growth Potential

Thermo Fisher Scientific Inc. (NYSE: TMO) stands out in the healthcare sector as a formidable entity within the diagnostics and research industry. With a staggering market capitalization of $215.01 billion,..

UnitedHealth Group Incorporated (UNH) Stock Analysis: A Look at Its 14.74% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, presents an intriguing opportunity for investors. With a substantial market capitalization of $309.65 billion, the company’s dynamic presence in..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Remarkable 8.45% Upside Potential

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare sector, specifically within the healthcare plans industry. With a substantial market capitalization of $80.85 billion, Elevance Health..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring the 87.97% Upside Potential

Investors with a keen eye on the healthcare sector might find Treace Medical Concepts, Inc. (NASDAQ: TMCI) an intriguing opportunity, especially in light of its impressive potential upside of 87.97%...

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Growth Challenges with Strategic Alliances

Investors eyeing the healthcare sector might find Myriad Genetics, Inc. (NASDAQ: MYGN) a compelling yet complex prospect. As a leader in molecular diagnostic testing and precision medicine, Myriad’s portfolio offers..

AngioDynamics, Inc. (ANGO) Poised for Growth: 44% Upside Potential Amid Robust Analyst Ratings

AngioDynamics, Inc. (ANGO), a key player in the healthcare sector, is drawing significant attention from individual investors, thanks to a compelling 43.85% upside potential as suggested by the average target..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Robust Potential Upside Amid Healthcare Challenges

Emergent BioSolutions Inc. (NYSE: EBS) presents an intriguing opportunity for investors, particularly in the healthcare sector. With a current market capitalization of $625.27 million, this Gaithersburg, Maryland-based company operates within..

Prothena Corporation plc (PRTA) Stock Analysis: Biotechnology Innovator with Nearly 97% Potential Upside

Prothena Corporation plc (PRTA), a prominent player in the biotechnology sector, has been making waves with its innovative approaches to treating neurodegenerative diseases. Based in Dublin, Ireland, this late-stage clinical..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Biotechnology Innovator with 81.55% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a promising player in the biotechnology sector, has been catching the eye of investors with its ambitious approach to treating central nervous system (CNS) disorders...

Abivax SA (ABVX) Stock Analysis: What Investors Should Know About Its 52-Week High and Analyst Consensus

Abivax SA (ABVX) has captured the attention of investors with a remarkable ascent to its current price of $133.09, marking the peak of its 52-week range, which started at a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds